Do you find our website to be helpful?
Yes   No

Apollo™ Onyx™ Delivery Micro Catheter

Micro Catheter Image

We participated in a post-market safety study to evaluate the new Apollo Onyx micro catheter. The purpose of this study is to evaluate the safety of the Apollo™ Onyx™ Delivery Micro Catheter used for delivery of the Onyx™ Liquid Embolic System during brain arteriovenous malformation (AVM) embolization procedures.

If you would like to explore more clinical information about this trial, please see the trial page on ClinicalTrials.gov


Author
Richard Bellon, MD Dr. Richard Bellon is a Neurointerventional Surgeon in Denver, CO

You Might Also Enjoy...

COMPASS Trial: A Direct Aspiration First Pass Technique

Intravenous (IV) tissue plasminogen activator (tPA) administration has been shown to be safe and effective for treatment of Acute Ischemic Stroke (AIS) within 3 hours of symptom onset, and newer evidence has shown potential benefit out to 4.5 hours.

We Are Committed to Clinical Research

RIA has a rich history of participation in clinical research and innovation dating back to the 1980s.  Many of our physicians believe it is important to contribute to science and advance medicine.